
Loading, please wait...

Loading, please wait...

The Longitudinal Assessment of Bariatric Surgery (LABS) study followed patients for seven years after bariatric procedures, providing valuable evidence on the durability of outcomes beyond the early postoperative period. Long-term data are especially important in bariatric surgery because weight regain, recurrence of metabolic disease and late complications can influence the real-world value of an operation. At seven years, Roux-en-Y gastric bypass was associated with substantial sustained weight loss, with a greater average reduction than laparoscopic adjustable gastric banding in the study population. Diabetes remission also remained considerably more common after gastric bypass. For surgeons and multidisciplinary teams, the findings reinforce two principles. First, bariatric surgery can produce durable changes in weight and metabolic disease. Second, outcomes need to be interpreted over years rather than months, because the clinical trajectory continues long after the initial operation. The study also highlights why long-term follow-up is not optional. Nutritional monitoring, management of medications, surveillance for recurrence of obesity-related disease and assessment of quality of life remain essential parts of bariatric care. LABS therefore provides a useful framework for counselling patients: the goal is durable improvement in health, not simply an early postoperative reduction in weight.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The Longitudinal Assessment of Bariatric Surgery (LABS) study followed patients for seven years after bariatric procedures, providing valuable evidence on the durability of outcomes beyond the early postoperative period. Long-term data are especially important in bariatric surgery because weight regain, recurrence of metabolic disease and late complications can influence the real-world value of an operation. At seven years, Roux-en-Y gastric bypass was associated with substantial sustained weight loss, with a greater average reduction than laparoscopic adjustable gastric banding in the study population. Diabetes remission also remained considerably more common after gastric bypass. For surgeons and multidisciplinary teams, the findings reinforce two principles. First, bariatric surgery can produce durable changes in weight and metabolic disease. Second, outcomes need to be interpreted over years rather than months, because the clinical trajectory continues long after the initial operation. The study also highlights why long-term follow-up is not optional. Nutritional monitoring, management of medications, surveillance for recurrence of obesity-related disease and assessment of quality of life remain essential parts of bariatric care. LABS therefore provides a useful framework for counselling patients: the goal is durable improvement in health, not simply an early postoperative reduction in weight.
4 weeks back

A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
4 days back

Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back

Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
5 days back

A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
4 days back

Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
5 days back